首页 | 本学科首页   官方微博 | 高级检索  
     

选择性支气管动脉插管转铁蛋白受体单克隆抗体灌注治疗中晚期肺癌(附68例临床报告)
引用本文:高中度,茅爱武,邵维城,徐志明. 选择性支气管动脉插管转铁蛋白受体单克隆抗体灌注治疗中晚期肺癌(附68例临床报告)[J]. 上海生物医学工程, 1997, 0(2)
作者姓名:高中度  茅爱武  邵维城  徐志明
作者单位:上海同仁医院,上海同仁医院,上海同仁医院,上海同仁医院 上海 200050,上海 200050,上海 200050,上海 200050
摘    要:本文对68例中晚期肺癌进行选择性支气管动脉插管采用转铁蛋白受体单克隆抗体与表阿霉素、顺伯等药物制成偶联物灌注。结果显示,肿瘤明显消退24例(35.2%),部分消退36例(52.5%),无变化8例(12.3%),总有效率为87.7%。通过对支气管动脉插管,导向灌注疗法结果显示,本疗法优于周围静脉供药,且无严重并发症,副作用轻,不失为一种可供选择的治疗方法。

关 键 词:中晚期肺癌  支气管动脉插管  转铁蛋白受体单克隆抗体  表阿霉素

Intra - arterial Chemotherapy of Late Stage Lung Cancer using Conjugates of Monocolonal Antitransferrin Receptor Antibody and Chemotherapy Drugs (attatched a clinical report of 68 cases)
Gao Zhongdu Mao Aiwu Shao Weicheng Xu ZhimingShanghai St. Luke''''s Hospital. Intra - arterial Chemotherapy of Late Stage Lung Cancer using Conjugates of Monocolonal Antitransferrin Receptor Antibody and Chemotherapy Drugs (attatched a clinical report of 68 cases)[J]. Shanghai Journal of Biomedical Engineering, 1997, 0(2)
Authors:Gao Zhongdu Mao Aiwu Shao Weicheng Xu ZhimingShanghai St. Luke''''s Hospital
Abstract:In this article, we treated 68 cases of medium and late stage lung cancer through selective bronchial artery intra- arterial chemotherapy, using conjugates of monocolonal antotransferrin receptor antibody and chemotherapy drugs (such as pharmorubincin.cisplatin, etc.). The results showed; The rate of significant tumor shrinkage was 35.2% (24 cases), partial 52.5% (36 cases), and no changes of 12.3%(8 cases). The total effective rate was 87.7% . The results we got might suggest: compared to intra- arterial chemotherapy simply using chemotherapy drugs,this conjugated method would give better therapeutic efiect and slighter side efiect. It may be a new way to promote the therapeudc effect of interventional chemothera-py
Keywords:Late Stage Lung Cancer Bronchial Artery Monocolonal Antitransferrin Receptor Antibody
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号